Astellas Reports Second Phase III Win With Zolbetuximab In Stomach Cancer

Astellas
Astellas now has two succesful Phase III readouts for zolbetuximab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D